Skip Navigation



eCAM Advance Access published online on January 23, 2006

eCAM, doi:10.1093/ecam/nek013
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
3/1/99    most recent
nek013v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Belon, P.
Right arrow Articles by Khuda-Bukhsh, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belon, P.
Right arrow Articles by Khuda-Bukhsh, A. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2006). Published by Oxford University Press. All rights reserved.
Received September 1, 2005
Accepted December 26, 2005

Original Article

Can Administration of Potentized Homeopathic Remedy, Arsenicum Album, Alter Antinuclear Antibody (ANA) Titer in People Living in High-Risk Arsenic Contaminated Areas? I. A Correlation with Certain Hematological Parameters

Philippe Belon 1, Pathikrit Banerjee 2, Sandipan Chaki Choudhury 2, Antara Banerjee 2, Surjyo Jyoti Biswas 2, Susanta Roy Karmakar 2, Surajit Pathak 2, Bibhas Guha 2, Sagar Chatterjee 2, Nandini Bhattacharjee 2, Jayanta Kumar Das 2, and Anisur Rahman Khuda-Bukhsh 2 *

1 Boiron Lab, 20 rue de la Liberation, Sainte-Foy-Les-Lyon, France
2 Department of Zoology, University of Kalyani, Kalyani-741235, West Bengal, India

* To whom correspondence should be addressed.
Anisur Rahman Khuda-Bukhsh, E-mail: khudabukhsh_48{at}rediffmail.com


   Abstract

To examine whether elevated antinuclear antibody (ANA) titers reported in random human population of arsenic contaminated villages can be reverted to the normal range by administration of a potentized homeopathic drug, Arsenicum album, randomly selected volunteers in two arsenic contaminated villages and one arsenic-free village in West Bengal (India) were periodically tested for their ANA titer as well as various blood parameters in two types of experiments: ‘placebo-controlled double blind’ experiment for shorter duration and ‘uncontrolled verum fed experiment’ for longer duration. Positive modulation of ANA titer was observed along with changes in certain relevant hematological parameters, namely total count of red blood cells and white blood cells, packed cell volume, hemoglobin content, erythrocyte sedimentation rate and blood sugar level, mostly within 2 months of drug administration. Thus, Arsenicum album appears to have great potential for ameliorating arsenic induced elevated ANA titer and other hematological toxicities.

Keywords: antinuclear antibody (ANA); Arsenicum album; arsenic toxicity; blood cells; blood sugar; ESR; human; homeopathic remedy.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Evid Based Complement Alternat MedHome page
A. Banerjee, S. B. Chakrabarty, S. R. Karmakar, A. Chakrabarty, S. J. Biswas, S. Haque, D. Das, S. Paul, B. Mandal, B. Naoual, et al.
Can Homeopathy Bring Additional Benefits to Thalassemic Patients on Hydroxyurea Therapy? Encouraging Results of a Preliminary Study
Evid. Based Complement. Altern. Med., October 29, 2007; (2007) nem161v1.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
J. R. Moffett, P. Arun, and M. A. A. Namboodiri
Laboratory Research in Homeopathy: Con
Integr Cancer Ther, December 1, 2006; 5(4): 333 - 342.
[Abstract] [PDF]


Home page
Evid Based Complement Alternat MedHome page
P. Bellavite, R. Ortolani, F. Pontarollo, V. Piasere, G. Benato, and A. Conforti
Immunology and Homeopathy. 4. Clinical Studies--Part 1
Evid. Based Complement. Altern. Med., September 1, 2006; 3(3): 293 - 301.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.